Article
Nuclear medicine patients do not have higher mutant frequencies after exposure to thallium-201.
Mutation research - 1 Jan 1991
Bachand M, Seifert A M, Messing K
Abstract excerpt
The HPRT-lymphocyte clonal assay has been used to detect mutants induced in vivo in humans. This method has previously detected a rise in mutant frequency among nuclear medicine patients following exposure to technetium-99m, at a dose corresponding in theory to 5.1 mGy. In the present study, nuclear medicine patients were sampled before and after exposure to thallium-201, corresponding to a whole-body dose of 4.2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
